334 related articles for article (PubMed ID: 2990694)
21. Diversity of clinical spectrum of HTLV-III infection.
Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and therapy of pneumocystis carinii pneumonia in a patient with AIDS].
Schur W; Asamer H
Wien Klin Wochenschr; 1986 Mar; 98(5):137-41. PubMed ID: 3008447
[TBL] [Abstract][Full Text] [Related]
23. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
[TBL] [Abstract][Full Text] [Related]
24. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
25. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
26. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.
Nicholson JK; McDougal JS; Spira TJ; Cross GD; Jones BM; Reinherz EL
J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564
[TBL] [Abstract][Full Text] [Related]
27. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
[No Abstract] [Full Text] [Related]
28. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
29. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men.
Rinaldo CR; Kingsley LA; Lyter DW; Rabin BS; Atchison RW; Bodner AJ; Weiss SH; Saxinger WC
J Infect Dis; 1986 Oct; 154(4):556-61. PubMed ID: 3018092
[TBL] [Abstract][Full Text] [Related]
30. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
[TBL] [Abstract][Full Text] [Related]
31. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
32. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
33. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
[TBL] [Abstract][Full Text] [Related]
34. [Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups].
Wachter H; Blecha HG; Fuchs D; Hausen A; Hengster P; Hinterhuber H; Reibnegger G; Reissigl H; Rössler H; Schönitzer D
Wien Klin Wochenschr; 1986 Jul; 98(14):449-54. PubMed ID: 3019018
[TBL] [Abstract][Full Text] [Related]
35. Lymph node immunohistology in intravenous drug abusers with persistent generalized lymphadenopathy.
Carbone A; Manconi R; Poletti A; Tirelli U; De Paoli P; Santini G; Diodato S; Manconi PE; Grigoletto E; Santi L
Arch Pathol Lab Med; 1985 Nov; 109(11):1007-12. PubMed ID: 2996460
[TBL] [Abstract][Full Text] [Related]
36. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS.
Biberfeld P; Porwit-Ksiazek A; Böttiger B; Morfeldt-Månsson L; Biberfeld G
Cancer Res; 1985 Sep; 45(9 Suppl):4665s-4670s. PubMed ID: 2410110
[TBL] [Abstract][Full Text] [Related]
37. Human retroviruses in health and disease.
Weiss RA
Princess Takamatsu Symp; 1984; 15():3-12. PubMed ID: 6100647
[TBL] [Abstract][Full Text] [Related]
38. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
39. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
[TBL] [Abstract][Full Text] [Related]
40. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
Tenner-Racz K; Racz P; Bofill M; Schulz-Meyer A; Dietrich M; Kern P; Weber J; Pinching AJ; Veronese-Dimarzo F; Popovic M
Am J Pathol; 1986 Apr; 123(1):9-15. PubMed ID: 3008562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
